Skip to main content
Premium Trial:

Request an Annual Quote

Invitae: Christine Gorjanc

Invitae has appointed Christine Gorjanc as interim CFO, effective July 1. In connection with her appointment, she resigned from the audit and compensation committees of the board, where she had served as an independent member. Gorjanc previously served as CFO of Arlo Technologies, a home automation company, and as CFO of Netgear, where she had previously served as chief accounting officer and VP of finance. Prior to that, Gorjanc served as VP, controller, treasurer, and assistant secretary at Aspect Communications and as manager of tax for Tandem Computers.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.